India Pulmonary Hypertension Symposium 2026
📅 28 February 2026 & 01 March 2026
📍 The Oterra Hotel, Electronic City, Bengaluru
A two-day meeting focused on advancing clinical practice, research, and collaboration in PH across India.
Bringing together leading national and international faculty across cardiology, pulmonology, surgery, radiology, anaesthesia, and critical care, the symposium will explore the latest evidence, practical approaches, and future directions in PH care.
Programme highlights
The agenda spans the full spectrum of PH, with a strong focus on real-world application and multidisciplinary management.
Key themes include:
- Latest guidelines and evidence
- Haemodynamics and imaging
- Novel therapies and PH in special populations
- Heart–lung transplantation and advanced care
- Interactive workshops
- Case-based discussions
Sessions will cover topics such as risk stratification in Group 1 PAH, PH associated with left heart and lung disease, congenital heart disease, acute PE and CTEPH, advanced therapies, ECMO, transplantation, and emerging drugs and devices
Organising committee
Consultant, Clinical Lead - Adult Heart Failure & Transplant: Adult Cardiology
Senior Consultant, Director - Heart Transplant Program Adult Cardiology
Senior Consultant, Director Lung Transplant Program: Interventional Pulmonology
Consultant - Pulmonology Lung Transplant Program: Interventional Pulmonology
Senior Consultant, Director - Heart Transplant Program Adult Cardiology
Senior Consultant, Clinical Lead - Paediatric Heart Transplant Paediatric Cardiology
Senior Consultant, Director - Paediatric Cardiology, Associate Director – Cath Lab Services
Senior Registrar - Pulmonology
Register now
Fee: ₹1500
Be part of two days of expert discussion, practical learning, and meaningful collaboration in PH. This symposium offers a valuable opportunity to deepen your knowledge, exchange ideas with peers, and strengthen multidisciplinary care across the region.
More from IDDI Workstream and Task Force Learning
Our IDDI Workstreams & Task Forces are actively finding practical solutions to the key challenges facing Pulmonary Hypertension (PH) physicians, academics, industry, and regulators; raising awareness of Pulmonary Vascular Disease (PVD); and addressing key challenges in its causes, effects, and treatment.